Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

KRX:185750 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	214,903	228,470	219,646	117,417	131,813	123,659
Short-Term Investments	66,751	72,549	143,095	8,871	-	4,869
Trading Asset Securities	2,046	1,152	2,324	29,573	55,520	33,328
Cash & Short-Term Investments	283,700	302,171	365,065	155,861	187,333	161,855
Cash Growth	-27.87%	-17.23%	134.22%	-16.80%	15.74%	75.22%
Accounts Receivable	265,112	266,742	269,632	248,409	203,598	183,288
Other Receivables	39,940	31,711	40,508	31,339	24,697	36,225
Receivables	305,052	298,453	310,140	279,749	228,295	219,514
Inventory	392,657	353,835	261,432	270,081	224,723	185,565
Prepaid Expenses	1,591	2,761	2,141	2,012	2,127	1,939
Other Current Assets	5,099	4,933	7,793	5,912	24,670	31,241
Total Current Assets	988,099	962,152	946,572	713,615	667,147	600,114
Property, Plant & Equipment	318,353	320,780	319,787	310,697	298,910	274,650
Long-Term Investments	41,593	42,035	41,144	44,010	33,373	26,564
Other Intangible Assets	77,774	74,512	52,062	26,953	20,806	19,033
Long-Term Deferred Tax Assets	31,177	29,668	14,213	6,209	2,350	-
Long-Term Deferred Charges	1,210	1,131	464.72	-	-	-
Other Long-Term Assets	27,256	28,486	28,186	23,399	24,114	25,972
Total Assets	1,485,464	1,458,765	1,402,428	1,124,883	1,046,700	946,333
Accounts Payable	220,919	200,148	183,939	145,436	129,327	144,120
Accrued Expenses	5,255	12,724	16,323	11,060	10,243	9,169
Short-Term Debt	64,530	64,616	90,959	96,270	74,656	73,049
Current Portion of Long-Term Debt	1,856	1,880	90,740	27,264	24,681	2,944
Current Portion of Leases	3,110	2,976	3,068	911.36	2,755	2,639
Current Income Taxes Payable	12,169	13,645	43,938	20,211	13,127	24,567
Current Unearned Revenue	21.17	21.96	20.08	5.46	5.83	9.2
Other Current Liabilities	87,370	72,549	82,478	73,054	65,435	64,124
Total Current Liabilities	395,230	368,559	511,466	374,213	320,230	320,621
Long-Term Debt	115,412	115,953	30,000	110,510	134,246	54,986
Long-Term Leases	2,531	2,727	4,997	782.86	715.88	2,523
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,631
Other Long-Term Liabilities	77,750	69,291	39,308	18,002	16,244	9,972
Total Liabilities	592,704	562,387	586,793	503,594	480,890	394,740
Common Stock	34,507	32,936	31,421	29,970	28,565	27,214
Additional Paid-In Capital	260,398	261,969	263,484	257,685	264,617	267,755
Retained Earnings	670,028	671,437	577,002	376,371	302,107	272,194
Treasury Stock	-65,920	-64,151	-48,143	-34,666	-22,435	-10,584
Comprehensive Income & Other	-8,705	-8,222	-8,070	-6,967	-6,843	-5,152
Total Common Equity	890,308	893,969	815,694	622,393	566,010	551,427
Minority Interest	2,451	2,409	-59.33	-1,104	-200.34	166.02
Shareholders' Equity	892,759	896,378	815,635	621,289	565,810	551,593
Total Liabilities & Equity	1,485,464	1,458,765	1,402,428	1,124,883	1,046,700	946,333
Total Debt	187,439	188,152	219,764	235,738	237,054	136,141
Net Cash (Debt)	96,261	114,018	145,301	-79,877	-49,721	25,714
Net Cash Growth	-45.41%	-21.53%	-	-	-	-
Net Cash Per Share	7285.50	8607.82	10399.38	-5933.68	-3628.24	1862.64
Filing Date Shares Outstanding	13.18	13.2	12.73	12.8	13.01	13.14
Total Common Shares Outstanding	13.18	13.2	13.36	13.44	13.66	13.79
Working Capital	592,869	593,594	435,106	339,402	346,917	279,493
Book Value Per Share	67550.26	67747.61	61048.89	46314.79	41433.07	39974.61
Tangible Book Value	812,534	819,456	763,632	595,440	545,204	532,394
Tangible Book Value Per Share	61649.29	62100.84	57152.39	44309.10	39910.06	38594.89
Land	113,398	112,346	111,145	116,028	108,235	106,346
Buildings	209,241	208,896	206,005	191,667	183,170	163,777
Machinery	333,188	331,375	292,292	274,583	252,066	226,051
Construction In Progress	10,472	7,383	21,716	19,946	19,901	20,029

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.